Algernon Pharmaceuticals Inc. (the "Company" or "AGN Pharma") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that its wholly owned subsidiary, Algernon ...

After a year, about 44% of participants following this combination were in remission for their type 2 diabetes, compared with 28% in a group prescribed a placebo rather than dapagliflozin, results ...

Interventions Calorie restriction with dapagliflozin 10 mg/day or placebo. Main outcome measures Primary outcome: incidence of diabetes remission (defined as glycated haemoglobin <6.5% and fasting ...

As hotel demand was crawling out of pandemic-era lows in 2022, Lloyd Goldman’s luxury resort on Montauk Beach was lauded as a beacon of hope. Goldman’s BLDG Management, in partnership with ...

Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its ...

The tagline: “You are the active ingredient.” Yes, it turns out. And in fact, many of us may have a similar placebo, of sorts, sitting in our medicine cabinets. It’s phenylephrine ...